News

Filter

Current filters:

BrintellixRegulation

Lundbeck’s Brintellix available in US pharmacies for depression

Lundbeck’s Brintellix available in US pharmacies for depression

22-01-2014

Lundbeck (LUN: CO) and Takeda Pharmaceutical (TYO: 4502) jointly announced today that Brintellix (vortioxetine)…

BrintellixLundbeckMarkets & MarketingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsUSA

Lundbeck’s Brintellix OKed in Europe for adults with depression

Lundbeck’s Brintellix OKed in Europe for adults with depression

29-12-2013

The European Commission has granted marketing authorization for Danish CNS specialist Lundbeck’s Brintellix…

BrintellixLundbeckNeurologicalPharmaceuticalRegulation

Positive EMA/CHMP opinions for Actelion and Lundbeck

Positive EMA/CHMP opinions for Actelion and Lundbeck

27-10-2013

At its October month-end meeting, the European Medicines Agency’s Committee for Medicinal Products…

ActelionBiotechnologyBrintellixEuropeLundbeckNeurologicalOpsumitPharmaceuticalRegulationRespiratory and Pulmonary

US FDA approves new drug Brintellix to treat major depressive disorder

US FDA approves new drug Brintellix to treat major depressive disorder

01-10-2013

The US Food and Drug Administration approved Brintellix on Monday, co-marketed by Takeda and Lundbeck…

BrintellixLundbeckNeurologicalNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

Back to top